Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Return-to-Play nach akuter Schulterverletzung – Eine Delphi-Konsensus-Studie

Autor: K. Schwandt, I. Buchholz, H. Bloch, C. Klein, J. Moock, Helge Riepenhof

Publikováno v: Sports Orthopaedics and Traumatology. 37:176-177

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60239ddaa26430b47a18f0f7a9c7cb33
https://doi.org/10.1016/j.orthtr.2021.04.016

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B.

Autor: Wilms G; Institute of Pharmacology and Toxicology, RWTH Aachen University, Wendlingweg 2, 52074 Aachen, Germany., Schofield K; Division of Drug Discovery and Development, Department of Pharmacology and Toxicology, College of Pharmacy The University of Arizona, Tucson, Arizona 85721, United States.; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Maddern S; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Foley C; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Shaw Y; Division of Drug Discovery and Development, Department of Pharmacology and Toxicology, College of Pharmacy The University of Arizona, Tucson, Arizona 85721, United States., Smith B; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Basantes LE; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Schwandt K; Institute of Pharmacology and Toxicology, RWTH Aachen University, Wendlingweg 2, 52074 Aachen, Germany., Babendreyer A; Institute of Molecular Pharmacology, RWTH Aachen University, Aachen 52074, Germany., Chavez T; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., McKee N; Division of Drug Discovery and Development, Department of Pharmacology and Toxicology, College of Pharmacy The University of Arizona, Tucson, Arizona 85721, United States., Gokhale V; BIO5 Institute, The University of Arizona, Tucson, Arizona 85721, United States., Kallabis S; Core Facility Translational Proteomics, Institute of Innate Immunity, University Hospital Bonn, Bonn 53127, Germany., Meissner F; Department of Systems Immunology and Proteomics, Institute of Innate Immunity, University Hospital Bonn, Bonn 53127, Germany., Rokey SN; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Dunckley T; ASU-Banner Neurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, Arizona 85281, United States., Montfort WR; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Becker W; Institute of Pharmacology and Toxicology, RWTH Aachen University, Wendlingweg 2, 52074 Aachen, Germany., Hulme C; Division of Drug Discovery and Development, Department of Pharmacology and Toxicology, College of Pharmacy The University of Arizona, Tucson, Arizona 85721, United States.; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2024 Oct 10; Vol. 67 (19), pp. 17259-17289. Date of Electronic Publication: 2024 Sep 30.